ARCHIVES

In Brief: Goldsmith Named CEO of CancerCare

This article is from The Cancer Letter archive.

Vol. 40 No. 15 | April 11, 2014

Download PDF Visit The Full Archive

Related Articles

Extramural Advisory Board Members Listed

October 20, 1995

FDA Approves Taxotere And Gemzar; Sends Approvable Letter For Etopophos

May 24, 1996

ODAC Votes to Nix Amgen’s Drug Xgeva For Proposed Prostate Cancer Indication

February 17, 2012

The Cancer Letter Obtains “Confidential” Documents From Duke IRB Investigation

May 14, 2010

In Brief: Three Centers Win Comprehensive Designation; Hiatt Named Deputy Director, NCI Cancer Control

October 31, 1997

Program Announcement In Preventative Oncology

May 21, 1982